Skip to main content

CORRECTION article

Front. Cell Dev. Biol., 07 December 2017
Sec. Molecular and Cellular Oncology

Corrigendum: A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine

  • 1Center for Biomedical Informatics and Information Technology, National Cancer Institute, Rockville, MD, United States
  • 2Science and Technology Policy Fellowship Program, American Association for the Advancement of Science, Washington, DC, United States
  • 3Office of Genomics and Advanced Technologies, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States
  • 4Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States

A corrigendum on
A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine

by Hinkson, I. V., Davidsen, T. M., Klemm, J. D., Kerlavage, A. R., and Kibbe, W. A. (2017). Front. Cell Dev. Biol. 5:83. doi: 10.3389/fcell.2017.00083

Ishwar Chandramouliswaran (currently National Institute of Allergy and Infectious Diseases) was not included as an author in the published article. The authors apologize for this error and state that this does not change the content of the article.

The original article has been updated.

Author Contributions

IH: Manuscript writing, figure design. TD, JK, AK, and WK: Manuscript and figure revision, approval of final manuscript. IH, TD, JK, IC, AK, and WK: Management and project support for Cancer Genomics Cloud Pilots.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: genomics, proteomics, imaging, big data, cancer, precision medicine, cloud infrastructure

Citation: Hinkson IV, Davidsen TM, Klemm JD, Chandramouliswaran I, Kerlavage AR and Kibbe WA (2017) Corrigendum: A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine. Front. Cell Dev. Biol. 5:108. doi: 10.3389/fcell.2017.00108

Received: 11 October 2017; Accepted: 24 November 2017;
Published: 07 December 2017.

Edited and reviewed by: Frontiers in Cell and Developmental Biology Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2017 Hinkson, Davidsen, Klemm, Chandramouliswaran, Kerlavage and Kibbe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Anthony R. Kerlavage, anthony.kerlavage@nih.gov

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.